PDS Biotechnology Corporation - Common Stock (PDSB)

DALLAS, TX - October 01, 2026 - Cancer immunotherapy, advanced DNA sequencing, Alzheimer’s research and predictive human tissue testing are putting seven healthcare companies on the 2026 watchlist. ImmunityBio, Pacific Biosciences, IGC Pharma, VivoSim Labs, PDS Biotechnology, Connect Biopharma and AEON Biopharma offer distinct developments for investors to follow as the year enters its final quarter.

Sept. 15, 2026 - Small-cap stocks PDS Biotechnology Corporation (NASDAQ: PDSB), IGC Pharma, Inc. (NYSE: IGC), Peraso Inc. (NASDAQ: PRSO) and ReTo Eco-Solutions, Inc. (NASDAQ: RETO) are in focus following recent pullbacks, with each company carrying potential catalysts across cancer immunotherapy, Alzheimer's biotechnology and AI, military autonomy, defense technology and intelligent industrial equipment .

Sept. 15, 2026 - Investors looking across emerging-growth and small-cap stocks are watching Veea Inc. (NASDAQ: VEEA), Sphere 3D Corp. d/b/a DarkHorse Technologies (NASDAQ: ANY), DataMEDS AI, Inc. (NASDAQ: MEDS), MySize, Inc. (NASDAQ: MYSZ) and PDS Biotechnology Corporation (NASDAQ: PDSB) as developments spanning AI healthcare, AI infrastructure, GPU computing, defense technology and cancer immunotherapy create potential catalysts across the group.

Sept. 8, 2026 Mobix Labs Inc. (NASDAQ: MOBX) and Peraso Inc. (NASDAQ: PRSO) are gaining attention across the expanding defense technology market, with Mobix Labs securing its initial production order supporting the F-16 Fighting Falcon and Peraso positioning its 60GHz mmWave technology across military robotics, UAVs and autonomous systems .

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

NEW YORK, NY / ACCESSWIRE / December 5, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with PDS Biotechnology Corporation.

Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing CAGR. Cervical Cancer is a cancer arising from the cervix which is due to the abnormal growth of cells that have the ability […]